Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Hold” by Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has received an average recommendation of “Hold” from the eleven brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $5.81.

A number of research firms recently commented on DH. BTIG Research started coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th.

Definitive Healthcare Stock Performance

DH opened at $4.77 on Wednesday. The stock has a market cap of $551.04 million, a price-to-earnings ratio of -1.54, a PEG ratio of 3.44 and a beta of 1.39. The business has a 50 day moving average of $4.40 and a 200-day moving average of $4.73. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $10.62.

Insider Activity

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 14.84% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Millennium Management LLC bought a new position in Definitive Healthcare during the second quarter valued at approximately $9,283,000. Massachusetts Financial Services Co. MA raised its holdings in shares of Definitive Healthcare by 36.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after buying an additional 1,626,813 shares during the period. 272 Capital LP purchased a new stake in shares of Definitive Healthcare in the second quarter worth approximately $3,480,000. State Street Corp raised its holdings in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after buying an additional 317,952 shares during the period. Finally, Marshall Wace LLP purchased a new position in Definitive Healthcare during the 2nd quarter worth $1,535,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.